Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2023	Dec. 31, 2022
Cash and cash equivalents:
Cash and due from banks	$ 309,153	$ 329,864
Federal funds sold	1,789	2,150
Total cash and cash equivalents	310,942	332,014
Investment securities available for sale	180,376	176,067
Loans, net of allowance for credit losses of $35,915 and $30,351 at March 31, 2023 and December 31, 2022, respectively	3,177,411	3,077,200
Accrued interest receivable	19,026	18,340
Premises and equipment, net	28,504	28,662
Bank-owned life insurance	64,235	60,761
Non-marketable equity securities, at cost	14,751	14,618
Deferred tax asset, net	7,146	6,303
Fair value hedge assets	8,793	9,213
Right-of-use asset - operating leases	19,328	17,872
Core Deposit Intangible, net	1,090	1,131
Goodwill	18,034	18,034
Other assets	10,021	12,933
Total assets	3,859,657	3,773,148
Deposits:
Noninterest bearing	516,909	486,114
Interest bearing	2,805,624	2,750,032
Total deposits	3,322,533	3,236,146
Accrued interest payable	1,636	2,545
Fair value hedge liabilities	7,271	9,221
Lease liability - operating leases	19,845	18,209
Other liabilities	10,054	14,024
Line of credit - Senior Debt	30,875	30,875
Note payable - Subordinated Debt, net	80,399	80,348
Total liabilities	3,472,613	3,391,368
Shareholders' equity:
Series A Convertible Non-Cumulative Preferred Stock	69	69
Common stock, $1 par value; 50,000,000 shares authorized; 13,657,960 and 13,610,198 issued; and 13,579,498 and 13,531,736 outstanding at March 31, 2023 and December 31, 2022, respectively	13,658	13,610
Additional paid-in capital	318,350	318,033
Retained earnings	58,182	53,270
Accumulated other comprehensive loss	(2,116)	(2,103)
Treasury stock: at cost; 78,462 shares at March 31, 2023 and December 31, 2022, respectively	(1,099)	(1,099)
Total shareholders' equity	387,044	381,780
Total liabilities & shareholders' equity	$ 3,859,657	$ 3,773,148